✦ LIBER ✦

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non Small-Cell Lung Cancer

✍ Scribed by Heymach, J. V.; Johnson, B. E.; Prager, D.; Csada, E.; Roubec, J.; Pesek, M.; Spasova, I.; Belani, C. P.; Bodrogi, I.; Gadgeel, S.; Kennedy, S. J.; Hou, J.; Herbst, R. S.

Book ID: 125518988
Publisher: American Society of Clinical Oncology
Year: 2007
Tongue: English
Weight: 209 KB
Volume: 25
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2006.10.5122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Study of Erlotinib P

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer

✍ Sequist, L. V.; von Pawel, J.; Garmey, E. G.; Akerley, W. L.; Brugger, W.; Ferra 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Docetaxel plus nintedanib versus docetax

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

✍ Reck, Martin; Kaiser, Rolf; Mellemgaard, Anders; Douillard, Jean-Yves; Orlov, Se 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 382 KB

212 Presentation of a Flims study: Rando

212 Presentation of a Flims study: Randomized phase II study of docetaxel/oxaliplatin and docetaxel in previously treated non-small cell lung cancer patients

✍ O. Belvedere 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Gefitinib versus docetaxel in previously

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

✍ Jiang, Jingwei; Huang, Lizhen; Liang, Xiaohua; Zhou, Xinli; Huang, Ruofan; Chu, 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 142 KB

Phase II Study of Docetaxel/Vinorelbine

Phase II Study of Docetaxel/Vinorelbine in Patients with non—small-Cell-Lung Cancer Previously Treated with Platinum-Based Chemotherapy

✍ Alberto Muñoz; Itziar Rubio; Juan Manuel Mañé; Josefa Ferreiro; Ricardo Fernánde 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 140 KB

Randomized phase II trial comparing tras

Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)

✍ Krug, L.M; Miller, V.A; Crapanzano, J.P; Zakowski, M.F; Ng, K.K; Heelan, R.T; Ro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB